Claudio Pietra

3.3k total citations · 1 hit paper
79 papers, 2.8k citations indexed

About

Claudio Pietra is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Claudio Pietra has authored 79 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cellular and Molecular Neuroscience, 26 papers in Molecular Biology and 25 papers in Physiology. Recurrent topics in Claudio Pietra's work include Regulation of Appetite and Obesity (19 papers), Neuropeptides and Animal Physiology (16 papers) and Urinary Bladder and Prostate Research (14 papers). Claudio Pietra is often cited by papers focused on Regulation of Appetite and Obesity (19 papers), Neuropeptides and Animal Physiology (16 papers) and Urinary Bladder and Prostate Research (14 papers). Claudio Pietra collaborates with scholars based in Italy, United States and Japan. Claudio Pietra's co-authors include Stefan Catsicas, Marc Missotten, Michel Dubois‐Dauphin, Dominique Talabot, Iván Rodríguez, Jean‐Claude Martinou, Harald Frankowski, Julie K. Staple, David G. Trist and Stéfano Palea and has published in prestigious journals such as Neuron, Gastroenterology and Advanced Drug Delivery Reviews.

In The Last Decade

Claudio Pietra

79 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia

1994 934 citations Claudio Pietra et al. profile →

Peers

Countries citing papers authored by Claudio Pietra

Since Specialization

Citations

This map shows the geographic impact of Claudio Pietra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Pietra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Pietra more than expected).

Fields of papers citing papers by Claudio Pietra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Pietra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Pietra. The network helps show where Claudio Pietra may publish in the future.

Co-authorship network of co-authors of Claudio Pietra

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Pietra. A scholar is included among the top collaborators of Claudio Pietra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Pietra. Claudio Pietra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays	European Journal of Pharmacology	Chiara Ruzza, Federica Ferrari et al.	1
2	Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors	Blood Advances	Afua A. Mensah, Filippo Spriano et al.	12
3	Behavioural characterization of ghrelin ligands, anamorelin and HM01: Appetite and reward-motivated effects in rodents	Neuropharmacology	Barbara Chruścicka, Daniela Felice et al.	8
4	The GLP-2 analogue elsiglutide reduces diarrhoea caused by the tyrosine kinase inhibitor lapatinib in rats	Cancer Chemotherapy and Pharmacology	Bronwen J. Mayo, Kate R. Secombe et al.	20
5	<p>Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics</p>	Journal of Experimental Pharmacology	Tijs Louwies, Claudio Pietra et al.	3
6	Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse Model	Endocrinology	Juan A. Rodriguez, Emily C. Bruggeman et al.	21
7	Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models	European Journal of Pharmacology	A Chiorazzi, Krystyna M. Wozniak et al.	13
8	Netupitant, a Potent and Highly Selective NK1 Receptor Antagonist, Alleviates Acetic Acid-Induced Bladder Overactivity in Anesthetized Guinea-Pigs	Frontiers in Pharmacology	Stéfano Palea, Emanuela Lovati et al.	5
9	In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant	Peptides	Chiara Ruzza, Anna Rizzi et al.	7
10	The new selective glp-2 receptor agonist, elsiglutide, improves irinotecan-induced diarrhoea and mucositis in the rat	Adelaide Research & Scholarship (AR&S) (University of Adelaide)	Bronwen J. Mayo, Emma Bateman et al.	3
11	Apoptosis, proliferation and inflammation are improved after treatment with the new selective glp-2 receptor agonist, elsiglutide, in a rat model of irinotecan-induced mucositis	Adelaide Research & Scholarship (AR&S) (University of Adelaide)	Bronwen J. Mayo, Andrea M. Stringer et al.	1
12	Synergistic Effect of 5-Hydroxytryptamine 3 and Neurokinin 1 Receptor Antagonism in Rodent Models of Somatic and Visceral Pain	Journal of Pharmacology and Experimental Therapeutics	Beverley Greenwood–Van Meerveld, Karl R. Tyler et al.	18
13	Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with gene-deleted mice and the selective receptor antagonist netupitant	Inflammation Research	Erika Pintér, Anikó Perkecz et al.	12
14	Comparison of the effects of netupitant and tolterodine on overactive bladder induced by intravesical acetic acid infusion in anesthetized female guinea-pigs.	Neurourology and Urodynamics	Stéfano Palea, Sergio Cantoreggi et al.	2
15	The Antiemetic 5-HT3 Receptor Antagonist Palonosetron Inhibits Substance P-Mediated Responses In Vitro and In Vivo	Journal of Pharmacology and Experimental Therapeutics	Camilo Rojas, Ying Li et al.	108
16	Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain	Journal of Pharmacology and Experimental Therapeutics	Gino Villetti, M. A. C. M. Bergamaschi et al.	66
17	Cyclodextrins in oligonucleotide delivery	Advanced Drug Delivery Reviews	Enrico Redenti, Claudio Pietra et al.	53
18	In vivo neurochemical effects of the acetylcholinesterase inhibitor ENA713 in rat hippocampus	Brain Research	Luigia Trabace, Addolorata Maria Luce Coluccia et al.	18
19	Middle cerebral artery occlusion alters neurotransmitter activities in ipsilateral and contralateral rat brain regions: an ex vivo voltammetric study	Neuroscience Letters	Francesco Crespi, Claudio Pietra	16
20	Induction of NADPH-diaphorase Activity in the Rat Forebrain after Middle Cerebral Artery Occlusion	Experimental Neurology	Zechun Peng, Claudio Pietra et al.	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact